baber/WOPTO huggingface dataset:
Patent DE-69931571-T2 (DE)
Inventor: STEPHENSON DONALD H
IPC: B32B15/04
Filed: 1999-09-30
Granted: 2007-05-24
Abstract: An anodized pressed valve metal powder pellet is described. The anodized pellet is particularly useful as an anode in an electrolytic capacitor having an improved breakdown voltage. The anodized pellet is formed by periodically holding the pellet at a constant voltage and allowing the current to decay over a period of time, or by turning the formation power supply off altogether during the anodization process. Either way provides an opportunity for heated electrolyte to diffuse from the anodized pellet.
Patent HU-E028361-T2 (HU)
Title: Antigen binding proteins capable of binding thymic stromal lymphopoietin
Inventor: COMEAU MICHAEL R
IPC: C07K16/24
Filed: 2008-09-09
Abstract: The present disclosure provides compositions and methods relating to antigen binding proteins which bind to human thymic stromal lymphopoietin (TSLP), including antibodies. In particular embodiments, the disclosure provides fully human, humanized and chimeric anti-TSLP antibodies and derivatives of such antibodies. The disclosure further provides nucleic acids encoding such antibodies and antibody fragments and derivatives, and methods of making and using such antibodies including methods of treating and preventing TSLP-related inflammatory and fibrotic disorders.
Patent HU-E028466-T2 (HU)
Title: A novel pharmaceutical preparation for preeclampsia.
Inventor: FALLON JOAN M
IPC: A61K38/43
Filed: 2009-03-13
Abstract: A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and the method for preparing the therapeutic agents is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the maternal GI tract to determine the likelihood of developing preeclampsia, pregnancy induced hypertension, and eclampsia/toxemia is disclosed.
Patent HU-E029973-T2 (HU)
Title: Process, process line and use of the process line for the production of freeze-dried particles
Inventor: LUY BERNHARD
IPC: F26B5/06
Filed: 2012-10-04
Abstract: A process line for the production of freeze-dried particles under closed conditions is provided, the process line comprising at least the following separate devices: a spray chamber for droplet generation and freeze congealing of the liquid droplets to form particles, and a bulk freeze-dryer for freeze drying the particles, wherein a transfer section is provided for a product transfer from the spray chamber to the freeze-dryer, for the production of the particles under end-to-end closed conditions each of the devices and of the transfer section is separately adapted for closed operation, and the spray chamber is adapted for separation of the liquid droplets from any cooling circuit.
Patent MD-3334705-T2 (MD)
Inventor: LACORTE ANDREA
IPC: C11C3/08
Filed: 2016-08-09
Abstract: Prezenta invenţie se referă la un procedeu de preparare a unui amestec de acizi graşi cetilaţi şi la un sistem pentru realizarea procesului menţionat. În plus, prezenta invenţie se referă la o compoziţie cuprinzând, sau, alternativ, constând din, amestecul menţionat de acizi graşi cetilaţi. În sfârşit, prezenta invenţie se referă la compoziţia menţionată pentru utilizare în tratamentul şi/sau prevenţia următoarelor: (i) artrita reumatoidă cu origine inflamatoare sau ne-inflamatoare, în particular osteoartrita; (ii) alte tulburări inflamatorii ale articulaţiilor; (iii) psoriazis, lupus, boli periodontale sau boli cardiovasculare sau cardiace; (iv) toate patologiile osteoarticulare post-traumatice inclusiv traumele sportive; (v) toate patologiile degenerative ale articulaţiilor (artroza, gonartroza, coxartroza, etc.), şi (vi) tulburările inflamatoare-traumatice ale tendoanelor şi muşchilor. Suplimentar, se prevede utilizarea compoziţiei prezentei invenţii în tratamentul şi/sau prevenţia patologiilor şi tulburărilor sus-menţionate (i)-(vi) în asociere cu o terapie de reabilitare. Compoziţia cuprinzând amestecul menţionat este formulată într-o formă farmaceutică pentru uz oral (novel food, supliment sau dispozitiv medical), sub formă de pilulă, pastilă, capsulă, comprimat, granule, pulbere dispersabilă, sirop, soluţie sau soluţie pulverizabilă; pentru utilizare topică sub formă de cremă, unguent, pomadă, gel sau spray pentru utilizare cum ar fi aplicarea pe piele, sau pentru utilizare transdermică sub forma unui plasture.
Patent TR-200103580-T2 (TR)
Inventor: CHEN ZHI XIAN
IPC: A01H1/00
Filed: 1999-06-11
Abstract: A method is disclosed for producing a transgenic cotton plant by Agrobacterium-mediated transformation of petiole tissue. The method comprises the steps of (a) obtaining cotton petiole explants, (b) exposing the petiole explants to a culture of Agrobacterium tumefaciens that harbors a vector comprising an exogenous gene and a selectable marker, the Agrobacterium being capable of effecting the stable transfer of the exogenous gene and selection agent resistance gene to the genome of the cells of the petiole explant, (c) culturing the petiole explants to induce callus formation, (d) selecting transformed callus that expresses the exogenous gene, (e) culturing the selected callus in suspension culture to induce formation of embryoids, (f) regenerating the embryoids into whole transgenic cotton plants.
Patent TR-200200029-T2 (TR)
Title: Bir aromatik bisoksazolinin hazırlanması
Inventor: BENTHEM RUDOLFUS ANTONIUS THEO
IPC: C08L101/00
Filed: 2000-06-27
Abstract: Bulus bir aromatik bisoksazolinin hazirlanmasi için olan bir islem ile ilgilidir, burada bir birinci adimda bir aromatik karboksilik asit veya bunun bir esteri bir alkanolamin ile tepkimeye girer, bundan sonra elde edilen hidroksialkilamid bir ikinci adimda bir katalizörün varliginda bir aromatik bisoksazoline dönüstürülür. Katalizör fosfinik asit, bir (C1-C26)alkil fosfinik asit, bir (C6-C20)aril fosfinik asit veya bu asitlerin birinden türetilen bir ester veya bir anhidrürdür.
Patent TR-200200814-T2 (TR)
Title: Üzerinde aktarılabilen, hava alabilir bir cilt bakımı bileşimine sahip eşya.
Inventor: VEGA VICTOR NICHOLAS
IPC: A61K8/63
Filed: 2000-09-20
Abstract: Bu bulus, en azindan bir kismi üzerine yerlestirilmis bir cilt bakimi bilesimine sahip bir esyaya iliskindir. Cilt bakimi bilesimi, esya üzerinde hareketsizlestirilebilen ve temasla, giyen kisinin normal hareketiyle ve/veya vücut isisiyla giyen kisinin cildine aktarilabilen, hava albilir, bariyer koruyucu bir bilesimdir. Özel olarak, cilt bakimi bilesiminin, en azindan yaklasik 0.1 gm/m2/sa'lik bir su buhari geçirgenlik oranina ve Metilen Mavisi Boya Yöntemi ile ölçüldügünde, Hunter b ölçeginde, en azindan yaklasik -25 olan bir bariyer özelligine sahip olmasi gereklidir.
Patent DE-602004009571-T2 (DE)
Inventor: MARISSEN ROELOF
IPC: C08G83/00
Filed: 2004-06-10
Granted: 2008-07-31
Abstract: The present invention relates to a process for the production of an isotropic polymeric network comprising multifunctional molecules with a functionality, n, of at least 5 by contacting in a solvent an amount of the multifunctional molecules with an amount of a coupling agent, whereby through supramolecular chemistry a bond between the multifunctional molecule and the coupling agent is formed. <??>The invention furthermore relates to an isotropic polymeric network with a density lower than 1300 kg/m<3> and a specific Young's modulus of at least 0.007 GPa.m<3>/kg, shaped articles hereof and the use of the isotropic polymeric network as construction material.
Patent DE-602004010059-T2 (DE)
Inventor: KERI VILMOS
IPC: C07G5/00
Filed: 2004-07-26
Granted: 2008-09-11
Abstract: Provided is a method of purifying a macrolide, especially tacrolimus, that includes loading macrolide onto a bed of sorption resin and eluting with a suitable eluent such as a combination of water and tetrahydrofuran.
Patent DE-602004011611-T2 (DE)
Inventor: HAMMARLUND HENRIK
IPC: G08G5/04
Filed: 2004-08-31
Granted: 2009-01-29
Abstract: A system and a method for automatically avoiding collisions between own aircraft and other aircraft. The system comprises a computing unit (10), computing an fly away path for own aircraft, a sender (12), sending the computed own fly away path to the other aircraft, a receiver (14), receiving fly away paths from the other aircraft, and a collision handler (18), detecting an approaching collision bases on the own fly away path and the fly away paths received from the other aircraft, and activating a fly away maneuver upon detecting an approaching collision. The collision handler is adapted to receive information about commanded maneuvers of own aircraft, and to detect an approaching collision based on own aircraft maneuvers commanded during a time period between sending the computed own fly away path to the other aircraft and detecting the approaching collision.
Patent DE-602004011740-T2 (DE)
Inventor: UGO FRANCO
IPC: G07D11/00
Filed: 2004-12-13
Granted: 2009-02-05
Abstract: An equipment (22) for the automatic deposit of banknotes (23) comprising a transaction port (33) for receiving a stack (24) of banknotes, a separating device (36) for separating the constituting sheets of the stack (24), a validation device (37) for discriminating the constituting sheets as recognized banknotes and constituting sheets not recognized, a transport mechanism (38, 39) servo-dependent on the validation device to drag said constituting sheets along differentiated paths (72, 73) for the recognized banknotes and the constituting sheets not recognized, and a box assembly (51) adjacent to the transaction port. The box assembly (51) includes two storage boxes (53, 54) and is shiftable among at least three different positions. The three positions are associated with predetermined conditions of communication of the storage boxes (53, 54) with the transaction port (33), the separating device (36) and the transport mechanism (38, 39) to receive the stack, transfer the stack to the separating device, temporarily store as banknote sub-stack and as discard sub-stack the recognized banknotes and, respectively, the constituting sheets not recognized and to return, by request, the discard sub-stack and the banknote sub-stack.
Patent DE-60225565-T3 (DE)
Inventor: TANGHOJ ALLAN
IPC: A61M25/00
Filed: 2002-06-28
Granted: 2016-04-21
Abstract: The present invention is a catheter assembly allowing for non-contaminated insertion of a catheter into a urinarycanal. The assembly includes a package for the catheter and an applicator to be used for guiding the catheter into the urinary canal without touching the catheter by holding the catheter via walls of the applicator. The assembly further comprises clamping means for pressing the walls of the applicator into engagement with the catheter. The present invention further relates to an applicator with integrated clamping means to be used with the assembly.
Patent DE-69310207-T3 (DE)
Inventor: LAROSSA ROBERT
IPC: C12Q1/68
Filed: 1993-12-02
Granted: 2001-11-15
Abstract: PCT No. PCT/US93/11527 Sec. 371 Date Oct. 6, 1994 Sec. 102(e) Date Oct. 6, 1994 PCT Filed Dec. 2, 1993 PCT Pub. No. WO94/13831 PCT Pub. Date Jun. 23, 1994Subtle changes in environmental stress can now be detected and measured at sublethal levels as a generic response to environmental stress. The present invention provides a method to detect changes in the environmental stress level. The stress change is indicated as a change in the luminescence output of a genetically engineered microorganism. In the present invention, the luminescence gene complex is under the control of a stress inducible promoter.
Patent DE-69808620-T3 (DE)
Inventor: MARGUERRE WOLFGANG
IPC: A61P7/08
Filed: 1998-08-04
Granted: 2008-05-21
Abstract: A universally applicable blood plasma obtainable by a process comprising the steps of mixing blood or blood plasma of blood groups A and B optionally blood or blood plasma of blood group AB without admixing substantial amounts of blood or blood plasma derived from blood group 0.
Patent DK-1203817-T3 (DK)
Inventor: REED STEVEN G
IPC: C12Q1/68
Filed: 1996-08-30
Granted: 2006-08-14
Abstract: Compounds and methods for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more M. tuberculosis proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against M tuberculosis infection, or may be used for the diagnosis of tuberculosis.
Patent DK-1263739-T3 (DK)
Inventor: TAYLOR NIGEL PHILIP
IPC: A61P43/00
Filed: 2001-02-12
Granted: 2008-03-17
Abstract: The invention relates to crystalline salts of the compound (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid, as well as processes for their manufacture, pharmaceutical compositions containing them, and their uses.
Patent DK-1471871-T3 (DK)
Inventor: PLATA SALAMAN CARLOS
IPC: A61K38/18
Filed: 2002-01-24
Granted: 2007-09-17
Abstract: Co-therapy for the treatment of neurological dysfunctions comprising administration of one or more fructopyranose sulfamates and erythropoietin.
Patent DK-1399111-T3 (DK)
Inventor: BELLITY PHILIPPE
IPC: A61Q19/08
Filed: 2002-06-13
Granted: 2007-06-11
Abstract: The invention relates to a sterile injectable composition for aesthetic and/or reparative uses, characterised in comprising an effective amount of at least one colorant of an appropriate colour and a biocompatible vector to control the diffusion of said colorant on injecting said composition into the sub-cutaneous, sub-dermal, and/or intra-dermal layer precisely in the zone for treatment.
Patent DK-1422343-T3 (DK)
Inventor: HERTELENDI JOSEF
IPC: E01B29/24
Filed: 2003-10-29
Granted: 2009-08-03
Abstract: The press parts (8) on the undersides (7) of the levers (3) can be moved along a lift axis (10) in order to alter their height relative to the lever. The press parts can also be rotated about this lift axis.  The mounting device (1) has two opposing levers which can be pivoted about an axis (4) extending at right angles to the rail length direction using an adjustment cylinder (5). Each cylinder has a press part on its underside for contacting the clamp (2).
Patent DK-1509343-T3 (DK)
Inventor: PORTER JOHN ALAN
IPC: A61L11/00
Filed: 2003-05-02
Granted: 2008-04-28
Abstract: An apparatus and process for the separation, recovery and recycling of municipal solid waste (MSW) in which hot water 48 is added to shredded and homogenized MSW 2 as it enters a rotating feed preparation drum 34 equipped with internal lifter blades 36 . The blades 36 and rotation of the drum 34 cause mixing and pulping of the MSW before discharge into a rotating thermal processor 56 also equipped with lifter blades 58 and cone section 64 , and in which the moist MSW 2 is heated by heating the hot gases in the processor by a flame from burner 62 which converts the moisture in the MSW to steam. The steam permeates through the MSW as it is turned and lifted in the thermal processor 56 , causing further pulping. The now cooked and treated MSW 2 is then fed to a conveyor 68 for transportation to a trommel screen for the separation of recyclable components. In a preferred embodiment plugs 70, 72 of MSW are maintained at the exit and entrance to the thermal processor 56 and act to provide a seal to maintain and control the temperature within the thermal processor 56 by reducing the egress of steam therefrom.
Patent DK-1507463-T3 (DK)
Inventor: BAKKER ERWIN PAUL MARIA
IPC: A23N15/08
Filed: 2003-05-28
Granted: 2006-07-10
Abstract: Device for treating bulbous or tuberous plants, particularly onions, provided with a green end and a root end and a bulb axis extending therethrough, comprising means for holding the bulbs, means for cutting the green end and the root end off from the bulbs, means for by means of image registration determining the orientation in the device of the bulbs held in the holding means, and means for orienting the onions in an orientation adjusted to the cutting means on the basis of said determination.
Patent DK-1513583-T3 (DK)
Inventor: DALLE VALERY
IPC: A61M39/10
Filed: 2003-10-09
Granted: 2010-09-20
Abstract: The connector comprises two tubular sections of male and female type (1, 4) each with a tubing adaptor (1a, 4a) and a fitting (1b, 4b) at the other end. The female fitting has external grooves (6) for axial retention of a locking collar (7). This is fixed onto the male fitting by penetration of claws (3) in openings (8) of the collar.
Patent DK-1694599-T3 (DK)
Inventor: EDWIN EMIL
IPC: C01B3/26
Filed: 2003-11-21
Granted: 2008-12-15
Abstract: Process for the preparation of fibrous carbon which comprises contacting a metallic catalyst with a carbon-containing gas at elevated temperature, characterized in that said catalyst is sponge iron.
Patent DK-1562638-T3 (DK)
Inventor: TILL UWE PROF DR
IPC: A61K49/00
Filed: 2003-11-18
Granted: 2012-02-20
Abstract: Non-radiolabeled contrast agent (I) for lymph node imaging comprises particles with a color that can be distinguished from the color of human tissue with the naked eye. At least 90% of the particles have a size of 5-1500 nm.  Independent claims are also included for:  (1) production of (I) by reacting a dye with particles of the indicated size and removing unbound dye by column chromatography, centrifugation or filtration;  (2) production of (I) by heating an aqueous protein solution to a temperature at which the protein denatures and agglomerates, adding a dye, separating the stained protein and suspending it in water, sonicating the suspension to produce particles of the desired size, removing any undersized particles or free dye by filtration, and monitoring the particle size distribution with a light microscope;  (3) surgical tumor treatment comprising injecting (I) into the tumor or its immediate vicinity before the operation, waiting until the composition flows through the lymph system and reaches the sentinel lymph nodes, and surgically removing the tumor and stained lymph node(s) and checking the latter for metastases.
Patent DK-1622648-T3 (DK)
Inventor: XIANG RONG
IPC: A61K39/00
Filed: 2004-03-24
Granted: 2010-09-06
Abstract: A DNA vaccine suitable for eliciting an immune response against cancer cells comprises a DNA construct operably encoding a cancer-associated Inhibitor of Apoptosis-family protein and an immunoactive gene product, such as a cytokine or a ligand for a natural killer cell surface receptor, in a pharmaceutically acceptable carrier. A preferred cytokine is CCL21. Preferred ligands for a natural killer cell surface receptor include human MICA, human MICB, human ULBP1, human ULBP2, and human ULBP3. The cancer-associated Inhibitor of Apoptosis (IAP)-family protein is preferably a survivin protein or livin protein. Method of inhibiting tumor growth by administering the vaccine of the invention to a mammal is also described.
Patent DK-1722647-T3 (DK)
Inventor: CLIFFORD MIKE
IPC: A23L21/10
Filed: 2005-03-09
Granted: 2009-08-17
Abstract: The invention concerns the prebiotic effects of dark fruit and their juices such as blackcurrant, cranberry and pomegranate juices. The invention is also directed to the use of the a dark fruit or dark fruit juice for manufacture of an orally ingestable composition to promote health by promoting the growth of beneficial gut microflora. The beverage can be made from one or more dark fruit juices, in combination with other prebiotics and various other ingredients.
Patent DK-1710228-T3 (DK)
Inventor: HAUBENNESTEL KARLHEINZ
IPC: C09D7/43
Filed: 2006-04-03
Granted: 2011-09-19
Abstract: Biuret compounds (I) are new. Biuret compounds (I) of formula (R 2>-Y 1>-OCNH-R 1>-N-((CO-NH-R 3>-[Z-R 4>-Z-R 5>] a-NH)-CO-N-(R 2>-Y 1>-OCHN-R 1>)-(CONH-R 1>-NHCO-Y 1>-R 2>))-CONH-R 1>-NHCO-Y 1>-R 2>) are new. R 1>, R 3>-R 5>2-18C-alkyl, cycloalkyl, aryl or aralkyl; Y 1>O and/or NH; R 2>4-22C-alkyl, 3-18C-alkenyl, cycloalkyl, aralkyl, C mH 2m+1(O-C nH 2n) x-(O-CH(C 6H 5)-CH 2) u, C mH 2m+1(OOC-C vH 2v) x or X-C 6H 4-(O-C nH 2n) x-(O-CH(C 6H 5)-CH 2) u; m : 1-22; n : 2-4; x, u : 0-15; v : 4-5; X : 1-12C-alkyl or (C 6H 5) 1-4; Z : COO, NHCO, NHCOO and/or NHCONH; and a : 1-20. Independent claims are included for: (1) a method for the preparation of (I); and (2) the urethane- and/or uretdione (A) containing urea.
Patent DK-1915916-T3 (DK)
Inventor: PIETSCH WOLF-RUEDIGER
IPC: A43B3/10
Filed: 2006-10-25
Granted: 2009-04-06
Abstract: The piece (2) has a sleeve-shaped section (6) with a slot (4) in which the piece is slid in a plane of an insole of a sandal. A flat base section (8) fit on the insole passes into the section (6). The flat section (8) in a top view has a breadth of 40 millimeters and a length of 60 millimeters, where the thickness of the section (8) is of 2.5 millimeters in unloaded condition. A contour (14) of raised and recessed areas (16, 18) is provided on an upper side (12) that faces a foot, where the raised area protrudes towards the recessed area around a preset length.
Patent DK-1877070-T3 (DK)
Inventor: SCHLINGENSIEPEN KARL-HERMANN
IPC: A61P37/06
Filed: 2006-05-04
Granted: 2009-03-02
Abstract: Use of at least one oligonucleotide with a length of from 8 to 30 nucleotide building blocks for manufacturing a pharmaceutical preparation for the prophylaxis and/or the treatment of diseases, that are modulated by TGF-beta1, TGF-beta3, VEGF, interleukin-10, c-jun, c-fos, and/or prostaglandin E2 in a mammal, wherein said oligonucleotide hybridizes with a messenger RNA of a TGF-beta1, TGF-beta3, VEGF, interleukin-10, c-jun, c-fos and/or prostaglandin E2 gene and wherein said preparation comprises said oligonucleotide in a concentration of about 1 microM to about 25 microM.
Patent DK-2077279-T3 (DK)
Inventor: SARIS CHRISTIAAN M
IPC: C07K19/00
Filed: 2001-06-28
Granted: 2012-12-03
Abstract: The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides.
Patent DK-1988401-T3 (DK)
Inventor: SHAPIRA JOSEPH
IPC: G01P5/26
Filed: 2008-04-23
Granted: 2012-05-14
Abstract: A method for crosswind velocity measurement including using a correlation between the atmosphere turbulence strength and the spatial scale spectrum of turbulence eddies in the atmosphere to calculate wind velocity. 
A scintillation pattern is analyzed using a time-lagged cross-correlation function, a dissymmetry is calculated for the cross-correlation function, for different values of a low band pass filter cut-off frequency. The cut-off frequency resulting in a maximum dissymmetry is closer, so that eddies with a long life-time are determining the measurement of wind velocity. 
Wind velocity is obtained from a determination of a specific frequency of the filtered signal, the distance to the object and the turbulence strength.
Patent DK-2048368-T3 (DK)
Inventor: FROEDIN STEN
IPC: F15B1/26
Filed: 2008-10-06
Granted: 2012-01-02
Abstract: A hydraulic fluid reservoir (10) has a generally rotational symmetric inner surface (12) including a tangentially oriented inlet (16) to cause a rotational motion in the reservoir when hydraulic fluid is flowing into the reservoir, and an outlet (18) for the hydraulic fluid. According to the invention,the reservoir has a screen (20) at the inlet (16) capable of guiding the inflow along the inner surface (12), and an opening (28, 32) to communicate the hydraulic fluid between the reservoir (10) and a buffer (42) of hydraulic fluid.